Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableLooking for participantsNCT02863757
What this trial is testing

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Who this might be right for
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
Humanity and Health Research Centre 1,500
Not applicableUnknownNCT04127370
What this trial is testing

The Role of Bariatric Surgeries in Management of Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDBariatric Surgery Candidate
Assiut University 95
Not applicableStudy completedNCT04845373
What this trial is testing

Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Gazi University 44
Testing effectiveness (Phase 2)WithdrawnNCT01466894
What this trial is testing

Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Immuron Ltd.
Post-approval studies (Phase 4)Ended earlyNCT01355575
What this trial is testing

Rifaximin in Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNAFLDNonalcoholic Steatohepatitis
Imperial College London 15
Not applicableNot Yet RecruitingNCT03282305
What this trial is testing

Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Great China Fatty Liver Consortium Limited 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550481
What this trial is testing

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Who this might be right for
Hepatocellular CarcinomaNonalcoholic Steatohepatitis
Northwestern University 35
Testing effectiveness (Phase 2)Study completedNCT05809934
What this trial is testing

Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
AstraZeneca 220
Not applicableStudy completedNCT05558592
What this trial is testing

Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease)

Who this might be right for
Metabolic DiseaseFatty Liver, Nonalcoholic
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700